“Oxiplex represents an important new adjunctive treatment for spine surgeons in the United States to address a significant unmet clinical need,” said Jeffrey Fischgrund, MD, Chairman of the Orthopedic Department at William Beaumont University Hospital (Royal Oak, MI) and principal investigator of the Oxiplex clinical studies. “Thanks to the commitment of our clinical sites, study coordinators, and patients, this technology is now available to benefit U.S. patients.”
